Schizophrenia as a membrane lipid disorder which is expressed throughout the body.
about
Inflammation and the two-hit hypothesis of schizophrenia.Bioactive lipids in schizophrenia.Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.Impaired metabolic reactivity to oxidative stress in early psychosis patientsImproving the physical health of patients with schizophrenia: therapeutic nihilism or realism?Dyslexia and familial high blood pressure: an observational pilot studyPrevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.The evolutionary paradox and the missing heritability of schizophrenia.The search for peripheral disease markers in psychiatry by genomic and proteomic approaches.Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugs.The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.Isoprostenes as indicators of oxidative stress in schizophrenia.The effects of ziprasidone, clozapine and haloperidol on lipid peroxidation in human plasma (in vitro): comparison.Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro.Oxidative stress in blood platelets from schizophrenic patients.The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial.A comparative genomic study in schizophrenic and in bipolar disorder patients, based on microarray expression profiling meta-analysis.
P2860
Q30422062-9F42B7ED-8D8E-4920-B5C0-2B51AEF1D9F6Q33246888-097526E2-86C9-46F5-9CF1-D3D830C41722Q33904833-4BF4FA1B-6DE5-4B0A-B185-3610B904FDFCQ34048645-874B0DEC-1763-47B1-9F95-381CDFB1D2FCQ34223748-90246095-27B8-4EFF-ACCE-2A376BD4C9E5Q35272108-CB43D966-2300-4D1C-90ED-ED2D73972637Q36508050-6CD6DD3F-7FE2-411C-9899-A99C51294C5EQ38077155-5FDA8440-5F4F-4E19-A67B-8F453DBF4DA2Q38089247-90C91085-3046-4A39-B99C-CDCDC293F786Q38816985-D344E00A-2E03-492D-A0F6-27BE43940818Q41286620-ADAF1CA3-73A4-41E8-93EF-911ED4921057Q43293458-6451D06A-2B2C-49BA-830D-09B1B75456FAQ45896435-28CF156C-D1F7-481B-92ED-BB0A0D5C2D4FQ46117836-08A096C4-227F-4E4E-BD01-F52077187911Q46763598-856C8781-D992-4563-9089-542D71D6308AQ50235068-4A4E2A53-DA37-4D44-9F5D-C0900DB9D145Q53678483-D305F29A-093E-4A9F-8178-61C3589ED31B
P2860
Schizophrenia as a membrane lipid disorder which is expressed throughout the body.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Schizophrenia as a membrane lipid disorder which is expressed throughout the body.
@en
type
label
Schizophrenia as a membrane lipid disorder which is expressed throughout the body.
@en
prefLabel
Schizophrenia as a membrane lipid disorder which is expressed throughout the body.
@en
P1476
Schizophrenia as a membrane lipid disorder which is expressed throughout the body.
@en
P2093
D F Horrobin
P356
10.1016/S0952-3278(96)90138-6
P577
1996-08-01T00:00:00Z